CLEANS Technique for the Treatment of Esophageal Food Impaction
NCT03570567 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-06-27
Summary
This clinical investigation is to evaluate the safety, performance, and efficacy of a novel endoscopic technique for resolving esophageal food impactions by using a novel hollow suction catheter, Piranha GI Aspiration Catheter, to core out and suction food away from the center of an impaction. This technique includes hollowing out the center of the impaction, thus reducing the volume of the food bolus in the center, allowing the food to collapse into the hollow center, and then allowing for spontaneous food passage into the stomach. The study design is based on the experience of the investigators and the general knowledge of the food impaction field. In addition, consideration was given to previous studies of endoscopic treatments for esophageal food impaction.
Conditions
- Esophageal Food Impaction
Interventions
- DEVICE
-
Piranha Treatment
The piranha device is used with an endoscope to breakup/dislodge the food bolus.
Sponsors & Collaborators
-
Biomerics, LLC
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-30
- Primary Completion
- 2018-09-30
- Completion
- 2018-09-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
NCT03420482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Pancreatic Polypeptide on Gastric Motor Function and Food Intake in Humans
NCT03854708 ·Status: COMPLETED ·Phase: PHASE4
-
Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients
NCT01742013 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
NCT00281502 ·Status: UNKNOWN ·Phase: PHASE2
-
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
NCT06843148 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
NCT05710315 ·Status: RECRUITING ·Phase: NA
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
Synbiotics Interventions for Managing Cirrhosis and Its Complications
NCT05687409 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life and Nutritional Improvements in Cirrhotic Patients
NCT01842113 ·Status: TERMINATED ·Phase: PHASE4
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
NCT01846806 ·Status: TERMINATED ·Phase: NA
-
Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease
NCT01614574 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
NCT06910943 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Role of Microbiome Reprogramming on Liver Fat Accumulation
NCT03914495 ·Status: TERMINATED ·Phase: NA
-
L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients
NCT03021876 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)
NCT03477903 ·Status: TERMINATED ·Phase: PHASE2
-
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
NCT03867487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control
NCT00744250 ·Status: TERMINATED ·Phase: PHASE4
-
Slowly Digestible Carbohydrates and the Ileal Brake
NCT03630445 ·Status: COMPLETED ·Phase: NA
-
Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency
NCT00095732 ·Status: COMPLETED ·Phase: PHASE2
-
N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy
NCT03499249 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
NCT01223742 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
NCT02010034 ·Status: COMPLETED ·Phase: NA
-
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
NCT00570765 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effect of Injection Lypolysis (Lipodissolve) Treatments to Reduce Body Fat
NCT00757081 ·Status: COMPLETED ·Phase: NA
-
Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
NCT00465751 ·Status: COMPLETED ·Phase: EARLY_PHASE1